InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 293441

Saturday, 04/15/2017 5:11:48 PM

Saturday, April 15, 2017 5:11:48 PM

Post# of 345706

Now, HS-110 may be a PS Targeting drug....is this possibly why Rahul stopped poppinv up at PPHM cc and also why Jeff Hutchins left and lands over at Heat Biologics... ?



Cold and Hot tumors seems to be the hot attraction theses days and "Checkmate Pharmaceuticals" also on that path...

"Checkmate Pharmaceutical’s Lead Product Candidate CMP-001, Is A CpG-A That Converts Immunologically “Cold” Tumors To Immunologically “Hot” Tumors"
http://checkmatepharma.com/technology

Reading the MOA it does not say exactly what it targets.... but says things similar to what PS Targeting does and says it makes checkpoint inhibitors work better...

I wonder how many are duplicating as much as they can....those PS Targeting traits...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News